Statistics for Randomized phase III trial of bleomycin, vindesine, mitomycin-C, and cisplatin (BEMP) versus cisplatin (P) in disseminated squamous-cell carcinoma of the uterine cervix: an EORTC Gynecological Cancer Cooperative Group study
Total visits
| views | |
|---|---|
| Randomized phase III trial of bleomycin, vindesine, mitomycin-C, and cisplatin (BEMP) versus cisplatin (P) in disseminated squamous-cell carcinoma of the uterine cervix: an EORTC Gynecological Cancer Cooperative Group study | 368 |
Total visits per month
| views | |
|---|---|
| December 2024 | 7 |
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 0 |
| April 2025 | 0 |
| May 2025 | 0 |
| June 2025 | 0 |
File Visits
| views | |
|---|---|
| Ann Oncol 967.pdf(legacy) | 391 |
| Ann Oncol 967.pdf | 3 |
Top country views
| views | |
|---|---|
| United States | 194 |
| China | 72 |
| United Kingdom | 15 |
| Portugal | 14 |
| France | 12 |
| Russia | 10 |
| Germany | 9 |
| Australia | 6 |
| India | 5 |
| Netherlands | 5 |
| Poland | 4 |
| Brazil | 3 |
| Argentina | 2 |
| European Union | 2 |
| Italy | 2 |
| United Arab Emirates | 1 |
| Canada | 1 |
| Colombia | 1 |
| Spain | 1 |
| Hong Kong SAR China | 1 |
| Japan | 1 |
| Mongolia | 1 |